A randomized, double-masked study to evaluate the efficacy of adding nepafenac 0.1% ophthalmic suspension to dexamethasone 0.1% on macular swelling after cataract surgery .

Trial Profile

A randomized, double-masked study to evaluate the efficacy of adding nepafenac 0.1% ophthalmic suspension to dexamethasone 0.1% on macular swelling after cataract surgery .

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Sep 2015

At a glance

  • Drugs Nepafenac (Primary) ; Dexamethasone
  • Indications Cataracts
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top